Open Access. Powered by Scholars. Published by Universities.®
- Discipline
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Serum Cholesterol Values In Acute Myocardial Infarctionpatients At King Chulalongkorn Memorial Hospital, Su. Suppapitiporn
Serum Cholesterol Values In Acute Myocardial Infarctionpatients At King Chulalongkorn Memorial Hospital, Su. Suppapitiporn
Chulalongkorn Medical Journal
No abstract provided.
The Long-Term Clinical Prognosis In Patients With Anterior Wall And Non-Anterior Wall Acute Myocardial Infarction Referred To Primary Percutaneous Transluminal Coronary Angioplasty, Mingzhong Zhao, Dayi Hu, Tianchang Li, Sanqing Jia
The Long-Term Clinical Prognosis In Patients With Anterior Wall And Non-Anterior Wall Acute Myocardial Infarction Referred To Primary Percutaneous Transluminal Coronary Angioplasty, Mingzhong Zhao, Dayi Hu, Tianchang Li, Sanqing Jia
Journal of the Hong Kong College of Cardiology
Objective: To investigate the long-term clinical prognosis in patients with anterior wall acute myocardial infarction (AW-AMI) and non AW-AMI (NAW-AMI) referred to primary percutaneous transluminal coronary angioplasty (P-PTCA). Methods: 287 patients with AMI who underwent P-PTCA were divided into AW-AMI group (142 cases) and NAW AMI group (145 cases) according to different sites of AMI. The baseline characteristics and coronary artery lesions of patients were analysed. The primary end points were in-hospital mortality and the major cardiovascular events (MACE) during a mean 17.3±9.8 months follow-up including the occurrences of non-fatal myocardial infarction, non-fatal congestive heart failure, revascularization of target vessels …
The Effects Of Ticlopidine In Acute Myocardial Infarction As An Adjunctive Treatment To Aspirin In An Intermediate Term Setting, V. Gökhan Ci̇n, Ahmet Temi̇zhan, Hasan Pekdemi̇r, Mehmet Tokaç, Okan Tartanoğlu
The Effects Of Ticlopidine In Acute Myocardial Infarction As An Adjunctive Treatment To Aspirin In An Intermediate Term Setting, V. Gökhan Ci̇n, Ahmet Temi̇zhan, Hasan Pekdemi̇r, Mehmet Tokaç, Okan Tartanoğlu
Turkish Journal of Medical Sciences
Antiplatelet therapy reduces the risk of subsequent ischemic events in patients suffering from acute myocardial infarction (AMI). In this respect, the multi-agent therapy to be used along with aspirin remains to be determined. In this study, ticlopidine was tried in AMI for its potential additive effects over aspirin. Ninety patients with similar clinical characteristics were involved and were followed up for 3 and 6 months. All patients were assigned to receive ticlopidine plus aspirin or aspirin alone. Major cardiac events such as death and reinfarction were primary end-points whereas the need for revascularization was the secondary end-point at 3 and …